SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-100177
Filing Date
2024-09-16
Accepted
2024-09-16 16:04:28
Documents
15
Period of Report
2024-09-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332800d24_8k.htm   iXBRL 8-K 33240
2 EXHIBIT 3.1 tm2332800d24_ex3-1.htm EX-3.1 42488
3 EXHIBIT 3.2 tm2332800d24_ex3-2.htm EX-3.2 76457
  Complete submission text file 0001104659-24-100177.txt   363383

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zbio-20240916.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zbio-20240916_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zbio-20240916_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2332800d24_8k_htm.xml XML 3913
Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42270 | Film No.: 241301048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)